Assertio Holdings任命Schwichtenberg为CTO，Pietrya为CCO

2024-12-12 21:37

Assertio Holdings (NASDAQ:ASRT) has announced the creation of a new Transformation Office and the appointment of Paul Schwichtenberg as Chief Transformation Officer.
Mr. Schwichtenberg currently serves as the company’s Chief Commercial Officer and was previously CFO.
In addition, Mary Pietryga will be appointed as Chief Commercial Officer, effective Dec. 16, 2024, with responsibility for sales, marketing and commercial access, taking over from Schwichtenberg.
Ms. Pietryga joins Assertio from Teva Pharmaceuticals, where she was Vice President and Head of the Global Biosimilar Portfolio.

More on Assertio Holdings